Gene · 3197
HOXA@: homeobox A cluster
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. HOXA@: homeobox A cluster. Genes, record 3197. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3197
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,025
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | HOXA@ papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 29 | 2025 |
| P01CA066996 | Development of Novel Therapeutic Strategies in Human Leukemias | 21 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 19 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 17 | 2025 |
| U10CA180886 | COG NCTN Network Group Operations Center - Year 11 STAR Act MCI and PEC Supplement | 13 | 2025 |
| ZIASC010378 | Activation of Proto-Oncogenes by Chromosomal Translocation | 13 | 2025 |
| U10CA180899 | Children's Oncology Group Statistics and Data Center | 11 | 2025 |
| R35CA197695 | Translating genomic discoveries to improved outcomes for high risk acute leukemia | 10 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 8 | 2025 |
| R01HG003143 | Structural Annotation of the Human Genome | 8 | 2025 |
1 to 10 of 2,025Source NIH's project files
See all 2,025 nih grantsPapers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Menin inhibitors in acute myeloid leukaemia: Mechanisms, clinical pharmacology, and emerging therapeutic strategies. | Crit Rev Oncol Hematol | 2026 | 42805358 | PubTator, text mining | PubMed |
| Targeting the Menin-KMT2A Axis in AML: Translating Molecular Insights into Therapeutic Success. | Clin Lymphoma Myeloma Leuk | 2026 | 42637611 | PubTator, text mining | PubMed |
| Mapping subcellular microenvironments using oligonucleotide-directed proximity labeling. | Curr Opin Chem Biol | 2026 | 42612587 | PubTator, text mining | PubMed |
| Toward a cell-type-specific lung HOX code. | Front Cell Dev Biol | 2026 | 42523700 | PubTator, text mining | PubMed |
| Disrupting a Convergent Acetylation Circuit Collapses Leukemic Identity Across AML Subtypes. | bioRxiv | 2026 | 42523331 | PubTator, text mining | PubMed |
Evaluation of Serum Long Non-Coding RNAs HOXA Transcript at the Distal Tip (HOTTIP), Colon Cancer-Associated Transcript 1 (CCAT1), and Colon Cancer-Associated Transcript 2 (CCAT2) as Potential Biomarkers in Schizophrenia. | Eurasian J Med | 2026 | 42364226 | PubTator, text mining | PubMed |
| ATRX inactivation disrupts global chromatin state and topology to dysregulate neurodevelopmental pathways in glioma pathogenesis. | Nucleic Acids Res | 2026 | 42339622 | PubTator, text mining | PubMed |
| The HOXA gene cluster: a critical regulator in bone-related disorders. | Ann Med | 2026 | 42296055 | PubTator, text mining | PubMed |
Differential DNA methylation in blood as potential mediator of the association between ambient PM2.5 and cerebrospinal fluid biomarkers of Alzheimer's disease among a cognitively normal population-based cohort. | Mol Psychiatry | 2026 | 42270761 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemias with Alterations of Lysine Methyltransferase 2A (KMT2A): Recent Therapeutic Developments. | Cancers (Basel) | 2026 | 42122138 | PubTator, text mining | PubMed |
1 to 10 of 3,264
See all 3,264 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3197
GET https://conductscience.org/api/genes/v1/3197/grants?page=2